Sort:
Date
Filter:
All

2,187 result(s) found

AdvanSix (ASIX) Now Trades Above Golden Cross: Time to Buy? https://www.zacks.com/stock/news/2330828/advansix-asix-now-trades-above-golden-cross-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2330828 Sep 03, 2024 - When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
'Golden era' for Hong Kong retail is over as Chinese tourists continue to tighten their purse strings https://www.cnbc.com/2024/09/03/golden-era-for-hong-kong-retail-is-over-as-chinese-tourists-continue-to-tighten-their-purse-strings.html Sep 03, 2024 - Real estate analysts claimed that the shopping frenzy the city once experienced will not return "for a long, long time."
Beat the Market Like Zacks: CareDx, Fair Isaac, 3M in Focus https://www.zacks.com/stock/news/2330748/beat-the-market-like-zacks-caredx-fair-isaac-3m-in-focus?cid=CS-ZC-FT-analyst_blog|investment_ideas-2330748 Sep 03, 2024 - Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Ski Resorts Are Stockpiling Snow to Get Through Warm Winters https://www.wired.com/story/ski-resorts-are-stockpiling-snow-to-get-through-warm-winters/ Sep 03, 2024 - Under protective coverings, piles of snow can be stored for a surprisingly long time, allowing ski resorts to mitigate some of the lack of snowfall caused by climate change.
Dodgers’ Shohei Ohtani returns to Anaheim amid playoff race, 50-50 chase https://www.ocregister.com/2024/09/02/dodgers-shohei-ohtani-returns-to-anaheim-amid-playoff-race-50-50-chase/ Sep 02, 2024 - Ohtani has already faced the Angels several times during spring training and in the regular season at Dodger Stadium, but this week’s games at the Big A are another reminder of his present vs. his past.
Earnings Estimates Moving Higher for New York Times (NYT): Time to Buy? https://www.zacks.com/stock/news/2330532/earnings-estimates-moving-higher-for-new-york-times-nyt-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2330532 Sep 02, 2024 - New York Times (NYT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Earnings Estimates Moving Higher for Datadog (DDOG): Time to Buy? https://www.zacks.com/stock/news/2330528/earnings-estimates-moving-higher-for-datadog-ddog-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2330528 Sep 02, 2024 - Datadog (DDOG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Earnings Estimates Moving Higher for Abercrombie (ANF): Time to Buy? https://www.zacks.com/stock/news/2330534/earnings-estimates-moving-higher-for-abercrombie-anf-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2330534 Sep 02, 2024 - Abercrombie (ANF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
NVIDIA's Data Center Sales Rise 154% in Q2: Time to Buy the Stock? https://www.zacks.com/stock/news/2330169/nvidia-s-data-center-sales-rise-154-in-q2-time-to-buy-the-stock?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2330169 Sep 02, 2024 - NVDA's long-term growth story is compelling, but issues like product delays and lofty valuations imply that now may not be the ideal time to buy aggressively.
SNY's MS Drug Meets Goal in One Phase III Study; Misses in Two Others https://www.zacks.com/stock/news/2330244/sny-s-ms-drug-meets-goal-in-one-phase-iii-study-misses-in-two-others?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2330244 Sep 02, 2024 - Sanofi's HERCULES phase III study on tolebrutinib meets primary endpoint, showing an improvement in delaying time to onset of confirmed disability progression.

Pages: 1...4344454647484950515253...219

<<<Page 48>